NASDAQ: NVCN
TSX: NVC
VANCOUVER, Nov. 7, 2016 /PRNewswire/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:
NVC) today announced that it will release its financial results for
the third quarter of 2016 on Monday, November 14, 2016, after
markets close. The Company will subsequently hold a conference call
that same day, Monday, November 14,
2016, at 4:30 pm Eastern Time hosted by
Mr. Alexei Marko, Chief Executive Officer, and Mr. Chris
Clark, Chief Financial Officer. A question and answer session will
follow the corporate update.
Conference Call
Details
|
|
DATE:
|
Monday, November 14,
2016
|
TIME:
|
4:30 pm ET
|
DIAL-IN
NUMBER:
|
888 390 0546 or 416
764 8688
|
A link to the live audio webcast of the conference call will
also be available on the Presentations and Events page of the
Investors section of Neovasc's website at
www.neovasc.com. Please connect at least 15 minutes prior to the
conference call to ensure adequate time for any software download
that may be required to hear the webcast.
A recording of the call will be available for 72 hours by
calling 888 390 0541 or 416 764 8677 and using passcode
981053#.
About Neovasc
Neovasc is a specialty medical device
company that develops, manufactures and markets products for the
rapidly growing cardiovascular marketplace. Its products in
development include the Tiara™, for the transcatheter treatment of
mitral valve disease and the Neovasc Reducer™ for the treatment of
refractory angina. The Company also sells a line of advanced
biological tissue products that are used as key components in
third-party medical products including transcatheter heart valves.
For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.